Orphan designation: recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8 Treatment of mastocytosis, 16/10/2017 Withdrawn
Orphan designation: anti-SIGLEC8 IgG1 humanised monoclonal antibody Treatment of eosinophilic gastroenteritis, 19/02/2021 Withdrawn
Orphan designation: sabatolimab Treatment of myelodysplastic syndromes, 20/08/2021 Withdrawn
Orphan designation: Ilginatinib maleate Treatment of myelofibrosis, 25/07/2023 Withdrawn
Orphan designation: adeno-associated viral vector serotype 8 containing the human acid alpha-glucosidase gene Treatment of glycogen storage disease type II (Pompe's disease), 16/04/2018 Withdrawn
Orphan designation: navitoclax Treatment of myelofibrosis, 16/12/2019 Withdrawn
Orphan designation: acalabrutinib Treatment of mantle cell lymphoma, 21/03/2016 Withdrawn
Orphan designation: pegylated adrenomedullin Treatment of acute respiratory distress syndrome (ARDS), 27/07/2020 Withdrawn
Second HMA/EMA multi-stakeholder forum on EudraVigilance and signal detection, Online, European Medicines Agency, Amsterdam, the Netherlands, 1 December 2026
Network Portfolio Roadmap